Other news

ADHD and impulsivity: new potential targets to approach the treatment for neuropsychiatric disorders

A study published in the journal Pharmacological Research describes the existence of a complex built by dopamine and noradrenergic receptors that could be a therapeutic target of potential interest to tackle the attention deficit hyperactivity disorder (ADHD) and impulsivity. The paper, a preclinical study, has been carried out by the Research Group on Molecular Neuropharmacology,

Development of a peptide that allows cannabis-derived drugs to relieve pain without side effects

An international team has developed a family of peptides that allow delta-9-tetrahydrocannabinol (THC), the main component of Cannabis sativa, to fight pain in mice without side effects. The study, published in the Journal of Medicinal Chemistry, counts with the participation of the coauthors Vicent Casadó and Estefanía Moreno, from the Molecular Neuropharmacology Research Group of

Childhood maltreatment alters the HOA-axis activity in early stages of life

A paper published in the journal Psychological Medicine confirms the existence of neurobiological alterations in early stages of life in minors exposed to maltreatment. The study’s first author is the researcher Laia Marqués-Feixa, from the Faculty of Biology, the Institute of Biomedicine of the UB (IBUB) and the CIBER Mental Health (CIBERSAM), and it has

IBUB researchers describe a new pathway of the energy metabolism in peripheral tissues regulated by cytokine GDF15

A study published in the journal Cell Reports describes a new pathway related to the activity of receptors that are associated with several metabolic or cardiovascular diseases such as diabetes, obesity and hypertension. According to the conclusions, many antidiabetic effects of the activators of the PPARβ/δ receptors ─potential therapeutic targets for the treatment of type

CaixaResearch call for Health Research promotes IBUB research

La Caixa Foundation announced today the thirty projects that were selected in the call CaixaResearch on Health Research 2021. The IBUB takes part in a project research. These are excellence projects on biomedicine and research on health presented by research centres and universities from Spain and Portugal, funded with a total of 22.1 million euros

Identified an early neuronal dysfunction in Parkinson’s that could help early diagnosis

Researchers from IBUB and IDIBELL have described that neurons derived from Parkinson’s patients show impairments in their transmission before neurodegeneration. For this study, it has been used dopaminergic neurons differentiated from patient stem cells as a model. Parkinson’s is a neurodegenerative disease characterized by the death of dopaminergic neurons. This neuronal death leads to a

La Marató 2020 promotes IBUB research project to fight COVID-19

La Marató de TV3 and Catalunya Ràdio in 2020, dedicated to COVID-19, will give 12.5 million euros to fund 36 excellence biomedical research projects to improve the quality and life expectancy of people affected by SARS-CoV-2. The 2020 edition received 229 projects, assessed by ninety-five scientists from international fields, experts on this issue. The assessment

5a Nit de la Biologia (SCB) – Awards

The SCB Awards recognize the outstanding contribution of the professionals of the biological sciences of the Catalan-speaking territories in the last year The SCB Scientific Article Award was given to the researcher Maria Isabel Hernández Álvarez, from IBUB, for her paper «Deficient endoplasmic reticulum-mitochondrial phosphatidylserine transfer causes liver disease», published in the prestigious scientific journal

Eight IBUB researchers among the 2% worldwide more influential researchers

A recent article published in PLOS Biology, presents a list of the 2% of scientists worldwide that lead different disciplines. This ranking has been conducted with the information provided by the Scopus database. Eight IBUB researchers (J. Argilés, X. Barril, J. Garcia-Fernández, R. Lavilla, F.J. Luque, D. Muñoz-Torrero, M. Rosés and  F. Villarroya), are among